In 2013 in Zurich, Switzerland, a new housing project for people with MCS will be complete. Environmental illness is widespread in Switzerland, with statistics from authorities estimating approximately 5000 affected people. The city of Zurich will help with the real estate and construction law of the housing project for the chemically injured. “The project, costing about 5.8 million francs will be remembered as a pioneering project for healthy living in Zurich’s history,” said city council member Marin Vollenwyder at a press conference today in Zurich. The city has set the goal for itself… “HOUSING FOR ALL,” which means the city also supports this chemically injured population which has a difficult time finding appropriate housing.

Hope is finally within reach

Christian Schifferle, the founder of this Healthy Living Project for those with MCS, and president of the self help support group, MCS League Switzerland, has waited many years for this project. Two years ago he founded this cooperative, and since then it has progressed in leaps and bounds. Today Christian Schifferle said in an e-mail:

“I just came from the media conference discussing the MCS apartment project in Zurich, and I’m still overwhelmed and barely managed to give my speech. The Neue Zürcher newspaper has published an article, and today or tomorrow a report will be on Tele Top. I will report the new details in my next email. Currently I am sleeping in my car but am promised a transitional solution for my accommodations.”

Architect commitment

There was more good news this week from Switzerland. Schifferle added that the Healthy Living MCS housing project will be strengthened by Marianne Dutli Derron, an architect who has worked as a consultant at Zurich SVW, which is the umbrella organization for over 200 housing associations in Zurich. Her office is directly next to the MCS housing association. Ms. Dutli Derron has been elected as the executive manager of this housing project, and will work with Dr. Roman Lietha and Christian Schifferle. At the next general meeting, Ms. Dutli Derron will be asked to be a board member and co-president. She brings eight years of experience as president of another Zurich housing project. A few weeks ago Schifferle asked the architect to join the MCS project and of course, is very pleased to have this commitment.

Professional support

The issue of MCS living is not new for Ms. Dutli Derron. She was one of the jury members for the MCS architectural competition on this project, and understands what is required to make this housing project a success. Christian Schifferle has offered his professional support which is crucial since he has suffered since childhood from severe MCS and knows much about the details needed for those with this environmental compromise. He has invested his energies for years in seeing this project become a reality. Difficult decisions over the coming months will be made during the construction phase. Support and expertise will be needed for the success of this healthy living project. Schifferle is anxious to relate the needs of the chemically injured population, and is thrilled to have Ms. Dutli Derron as a project expert on the board.

Healthy living has a big future

The city of Zurich while providing this housing project for those with MCS is taking on a pioneering project. It is the first residential project emerging for the chemically injured in Europe. In September 2009, the financial department of the city approved a loan of 150,000 francs for the implementation of a study for the residential building with ten apartments for MCS sufferers. The MCS house is designed from the ground up biologically and scientists offer their support on the residential project.

Technical and old workmanship combined

As the Zurich newspaper explains, the focus of this particular building is one of careful choices of safe building materials and expert workmanship. This structure will even be fitted with special locks so that the inhabitants can clean off chemical substances as they enter. This pioneering project will be challenging to build because of the use of old craft techniques, some of which have been forgotten, combined with modern safe materials.

Glass fiber rods will be used, which, until now, were never tried in structural engineering. The material conducts either heat or electricity. The MCS building will also try an external wall construction of insulating bricks with a variety of biologically active inner skin with clay and lime plaster. Perhaps this project will have unusual looking materials and processing techniques which are different from normal residential projects, but it is hoped that the architectural firm which has received the contract for this innovative project will emerge with a successful outcome on all levels. In addition the firm desires to give innovative input to traditional residential projects as well.

For Christian Schifferle (video), he must sleep for two more years, through long cold nights in the car or on the cot in the forest. After the enormous efforts that he has devoted to this project, he will hopefully have a home in which he and other MCS sufferers can live without symptoms, and thus experience real healthy living. As a next step, with Schifferle’s leadership, Germany will begin safe housing projects for healthy living as well. Perhaps eventually these projects will be prototypes for healthy living buildings for MCS sufferers around the globe.

Author: Silvia K. Müller, CSN – Chemical Sensitivity Network, Sept. 10, 2010

Translation: Thank you very much to Christi Howarth

Related Articles:

• Zurich targets first MCS Housing Project in Europe and issues an invitation to tender
• Cry for help – Young woman in danger
• New Housing Non-Profit Forming with Focus on Environmental Sensitivities
• The last few months of life of Angelika who was chemically sensitive
• An Italian Multiple Chemical Sensitivity Sufferer shouts an inconvenient truth with his death

For several years the Swedish Prof. Dr. Eva Millqvist researched the disease of hyperreactivity of the respiratory tract and the environmental condition of Chemical Sensitivity (MCS). She specializes in the range of responses to respiratory irritants.

Sick from odors and fragrances

Patients with respiratory symptoms which are triggered by chemicals and odors, are commonly found in allergy clinics. According to Millqvist and her team, these health problems are not explained by asthma or allergic reactions.

German patients frequently report that after they report reactions to chemicals or odors to their allergist, the prospect of seeing a psychologist has been recommended. Whether or not this recommendation is actually appropriate for these patients, it is precisely what this new study from Sweden addresses.

Studies showed reactions

Millqvist’s previous studies have shown that MCS patients often have an increased sensitivity to inhaled capsaicin. This ingredient of chili is famous sensory reactivity. A diagnosis of sensory hyperreactivity of the airways (SHR) is proposed for these kinds of complaints.

In a recent study this renowned scientist and two colleagues, sought to discover whether there is a relationship between asthma and sensory hyperreactivity (SHR). In addition, the research team wanted to investigate whether patients with signs of SHR had increased psychiatric morbidity (anxiety, depression, etc.).

Patients were subjected to tests and questionnaires

The researchers took 724 patients with suspected allergies or asthma from an asthma center. All patients had a questionnaire regarding reactions and behavioral disorders caused by fragrant substances.

A standardized Capsaicin test was carried out and then a questionnaire was given to assess psychiatric morbidity in patients with severe chemical sensitivity to identify those who suffer from SHR.

No evidence of depression or anxiety

Only about 6% of the asthma patients from the allergy center, who participated in the study, had sensory hyperreactivity (SHR). Millqvist and her colleagues stated that this is in consistent with the prevalence in the general Swedish population. There was no significant evidence that SHR is consistent with anxiety or is related to depression.

Patients should insist on precise diagnostic evaluation

The study appeared in the July 2010 issue of the medical journal “Annals of Allergy, Asthma & Immunology.” Those patients who respond to chemicals and odors with hyperreactive respiratory symptoms should perhaps seek an experienced environmental medicine professional if their allergist makes a reference to the possibility of a mental illness.

Author: Silvia K. Müller, CSN – Chemical Sensitivity Network, 2. September 2010.

Translation: Thank’s to Christi Howarth.

Literature:

Johansson A, Millqvist E, Bende M., Relationship of airway sensory hyperreactivity to asthma and psychiatric morbidity, Department of Respiratory Medicine, Central Hospital, Skövde, Sweden, Ann Allergy Asthma Immunol. 2010 Jul; 105(1):20-3.

People must be protected from exposure to fragrance ingredients that may cause cancer or fetal, hormonal or reproductive toxicity, the Cancer Prevention Coalition warned today. But federal agencies are not regulating these ingredients, leaving the public at risk due to the “recklessly irresponsible” behavior of the fragrance industry, says CPC Chairman Samuel S. Epstein, M.D.

Protection of the public would be implemented by passage of Senator Frank Lautenberg’s Safe Chemicals Act of 2010, Dr. Epstein advises. This bill requires manufacturers to provide information on “chemicals of concern” in consumer products.

The bill would provide the public with information on the dangers of these products, especially, says Dr. Epstein, “as the U.S. Food and Drug Administration (FDA) has recklessly failed to do so since passage of the 1938 Federal Food, Drug, and Cosmetic Act.”

Perfumes and fragrances are the single largest category of cosmetic and personal care products, especially products used on the hair, face, and eyes. These products represent nearly 50 percent of all prestige beauty dollars now spent in the United States. Fragrances are also extensively used in a wide range of everyday household cleaning products.

Exposure to toxic ingredients in cosmetics and personal care products is predominantly through the skin. In contrast, exposure to toxic ingredients in household cleaning products is predominantly through inhalation.

The FDA has direct authority under the terms of the 1938 Federal Food Drug and Cosmetic Act to regulate toxic ingredients in cosmetics and personal care products. However, seven decades later, it has still failed to do so. Similarly, the U.S. Environmental Protection Agency has also still failed to regulate these toxic ingredients in household cleaning products.

“In the disturbing absence of any federal regulations,” Dr. Epstein says, the policies and practices of the cosmetics and personal care products industries are determined by its International Fragrance Association (IFRA). This is an international trade organization of over 100 perfume and fragrance manufacturers, representing fifteen regions including the U.S., Europe, South America, Australia, and the Far East.”

The primary objective of IFRA is to protect the self-regulatory practices and policies of the industry by the development of a Code of Practices and safety guidelines, Dr. Epstein says. However, these include maintaining the “trade secret” status of perfume and fragrance ingredients, and pre-empting international legislative labeling and safety initiatives.

Of the more than 5,000 ingredients used in the fragrance industry, approximately 1,300 have so far been evaluated by the industry’s International Research Institute for Fragrance Materials. This institute is a “non-profit” organization, created by IFRA in 1966 to conduct research and testing of fragrance ingredients.

“However,” Dr. Epstein warns, “this testing is minimal and restricted to local effects on human skin, and short-term toxicity tests in rodents.”

Evaluation of ingredient safety is then made by a board of toxicologists, pharmacologists, and dermatologists, identified by the institute as “independent” without disclosure of their qualifications, let alone conflicts of interest.

Their findings are presented to IFRA’s Scientific Advisory Board, and then published in its trade journal, Food and Chemical Toxicology. The information reported in this journal is the basis on which IFRA formulates its own “safety guidelines.” However, Dr. Epstein points out, due to the “trade secret” status of fragrances, manufacturers are still not required by the FDA to disclose their ingredients on product labels or in any other way.

“These ingredients include a wide range of allergens. They also include synthetic musks, particularly tonalide and galaxolide, designed to mimic natural scents derived from musk deer and ox,” Dr. Epstein explains. “They are persistent and bioaccumulate in the body, have toxic hormonal effects, and have been identified in breast milk.”

In 1973, in efforts at damage control, IFRA created a Code of Practice listing prohibited ingredients, based on its own safety analyses. This listing has been periodically updated.

In May 1999, in response to repeated complaints of respiratory, neurological, and other toxic effects following the use of Calvin Klein’s Eternity perfume, the Environmental Health Network of California hired two testing laboratories to identify the ingredients in the perfume.

Analysis of these results by the Cancer Prevention Coalition, summarized in Dr. Epstein’s 2009 book Toxic Beauty, reveal the following:

• 26 ingredients whose “Toxicological properties have not been investigated,” or “toxicology properties have not been thoroughly investigated.”
• 25 ingredients that are “Irritants.”
• 5 ingredients that are “Skin sensitizers,” or allergens.
• 3 ingredients that show “Fetal, hormonal, and reproductive toxicity.”
• 2 ingredients that “May cause cancer.”

In efforts at damage control, IFRA agreed that information on allergenic ingredients in perfumes like Eternity should be made available, but only on request from dermatologists, for diagnostic purposes. “This “Fragrance On-Call List” action denies the public its right to know,” Dr. Epstein warns.

More disturbingly, Dr. Matthias Vey, president of IFRA, failed to respond to repeated warnings from August to October 2003 from the Cancer Prevention Coalition. These urged “all fragrance products be labeled to the effect that, apart from the absence of known skin and respiratory allergens, they contain no known carcinogens, gene damaging, hormonal, or otherwise toxic ingredients.”

As reported in “What’s That Smell,” a June 2010 report by Women’s Voices of the Earth, faced with continuing criticism of unresponsiveness, IFRA initiated a “compliance program” in 2007. “However,” Dr. Epstein warns, “this is based on testing of a mere 50 fragranced products from the global market place to detect prohibited ingredients.”

A fragrance may be restricted by IFRA on a variety of grounds. These include: use in products at higher-than-recommended concentrations, sensitization, photosensitization, phototoxicity, allergenicity, neurotoxicity, carcinogenicity, undefined biological effects, and inadequate data.

“This restriction, though, works better in theory than in practice,” Dr. Epstein emphasizes. “There is no pre-approval process for ingredient safety other than that claimed by the Research Institute for Fragrance Materials.”

Literature: Cancer Prevention Coalition, Reckless Self-Interest Of The Fragrance Industry, CHICAGO, IL, June 28, 2010

Related Articles:

• Secret Chemicals revealed in Celebrity Perfumes, Teen Body Sprays
• Household detergents, Shampoos may harmful substance in wastewater
• Phthalate Concentrations and Use of Personal Care Products among Pregnant Women
• Open Letter: Perfumed Stamps constrain People with Disabilities

First Perfume and Fragrance- free Asthma Conference

The American Environmental Protection Agency is holding a large asthma conference from June 17-19, 2010, in Washington D.C.. For the first time ever, the EPA has a special conference feature which is to renounce fragrances and perfume. Thus, the EPA is sending a signal to indicate the fragrance issue and to provide participants with asthma, the possibility to participate at the 2010 National Asthma Forum. Fragrances are among the principle factors for asthma attacks.

Nearly 300 experts and leaders, whose work is to improve the living conditions of people with asthma, are taking part in this event. Primary decision makers of federal and state authorities, as well as those responsible for guidelines, managers of health authorities, scientists, physicians and leaders of self-help organizations are included in this group. Their goal is to design environments to assist in safe living for all asthmatics.

In order to allow all participants to take part in the conference, meaning a conference free of perfume, aftershave, hairspray, body lotion, fabric softener or scented deodorants, the federal agency sent out the following reminder online:

“Asthma-friendly environments are our business – Please help us to make this a fragrance-free event by using fragrance-free personal care products and avoid perfumes and other irritants.”

This is a very positive step by the EPA. They have removed the largest known barrier for asthmatics and chemically injured people this year for the 2010 National Asthma Forum. World leaders on every continent should incorporate this humanitarian example by the EPA , for those disabled with illnesses affecting the breathing and lung function throughout the world.

Author: Silvia K. Müller, CSN – Chemical Sensitivity Network, 17 June 2010

Translation: Thank’s to Christi Howarth

Related Articles:

• Secret Chemicals revealed in Celebrity Perfumes, Teen Body Spray
• Open Letter: Perfumed Stamps constrain people with disability
• Professor urges us to take people with Chemical Sensibility into Account

A simple blood test can now predict whether newborn babies are at high risk of developing allergies as they grow older, thanks to research involving the University of Adelaide.

Professor Tony Ferrante, an immunologist from SA Pathology and the Children’s Research Centre at the University of Adelaide, says the new marker may be the most significant breakthrough in allergy testing for some decades.

“A protein in the immune cells of newborns appears to hold the answer as to whether a baby will either be protected, or susceptible to the development of allergies later on,” Professor Ferrante says.

Amounts of the cell signalling protein, called protein kinase C zeta, are much lower in children at risk of allergies.

Professor Ferrante says the blood test is far more effective than previous indicators, such as a family’s clinical history, or measuring the allergy-inducing antibody IgE.

In collaboration with Professor Susan Prescott from the University of Western Australia and Princess Margaret Hospital for Children, Professor Ferrante’s research team has refined the new marker for allergy risk, originally discovered in 2007, but now modified to a simple and manageable blood test at birth.

The researchers are also looking at whether fish oil supplements given to both pregnant women and those who have just given birth can reduce the risks of the children developing allergies.

“There is evidence that the levels of this important protein increase with fish oil supplementation to protect against allergy development,” Professor Ferrante says.

Australia has one of the highest allergy rates in the world, with 40% of children now suffering from allergic diseases, including food allergies, eczema, asthma and hay fever. These conditions frequently persist into adulthood, placing a heavy burden on the healthcare system.

Literature: The University of Adelaide, New blood test for newborns to detect allergy risk, 21 May 2010